Tyrosine kinase domain mutations of EGFR gene in head and neck squamous cell carcinoma

References

• SiegelRNaishadhamDJemalACancer statistics, 2012CA Cancer J Clin2012621102922237781
   PubMed Web of Science ®Google Scholar
• AgrawalNFrederickMJPickeringCRExome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1Science201133360461154115721798897
   PubMed Web of Science ®Google Scholar
• StranskyNEgloffAMTwardADThe mutational landscape of head and neck squamous cell carcinomaScience201133360461157116021798893
   PubMed Web of Science ®Google Scholar
• LeemansCRBraakhuisBJBrakenhoffRHThe molecular biology of head and neck cancerNat Rev Cancer201111192221160525
   PubMed Web of Science ®Google Scholar
• YewaleCBaradiaDVhoraIPatilSMisraAEpidermal growth factor receptor targeting in cancer: a review of trends and strategiesBiomaterials201334348690870723953842
   PubMed Web of Science ®Google Scholar
• MitsudomiTYatabeYEpidermal growth factor receptor in relation to tumor development: EGFR gene and cancerFEBS J2010277230130819922469
   PubMed Web of Science ®Google Scholar
• HirschFRVarella-GarciaMCappuzzoFPredictive value of egfr and her2 overexpression in advanced non-small-cell lung cancerOncogene200928Suppl 13237
   PubMedGoogle Scholar
• FranovicAGunaratnamLSmithKRobertIPattenDLeeSTranslational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancerProc Natl Acad Sci U S A200710432130921309717670948
   PubMed Web of Science ®Google Scholar
• ZaczekABrandtBBielawskiKPThe diverse signaling network of EGFR, HER2, HER3 and HER4 tyrosine kinase receptors and the consequences for therapeutic approachesHistol Histopathol20052031005101515944951
   PubMed Web of Science ®Google Scholar
• OlayioyeMANeveRMLaneHAHynesNEThe ErbB signaling network: receptor heterodimerization in development and cancerEMBO J200019133159316710880430
   PubMed Web of Science ®Google Scholar
• HanCBMaJTLiFZouHWMolecular markers for the prediction of anti-EGFR monoclonal antibody treatment efficacy in metastatic colorectal cancerJ Cancer Ther20112675682
   Google Scholar
• BabaYFujiiMTokumaruYKatoYPresent and future of EGFR inhibitors for head and neck squamous cell cancerJ Oncol2012201298672522545054
   PubMedGoogle Scholar
• SahooRHariniVVBabuVCScreening for EGFR mutations in lung cancer, a report from IndiaLung Cancer201173331631921315473
   PubMed Web of Science ®Google Scholar
• WykoskyJMukasaAFurnariFCaveneeWKEscape from targeted inhibition: the dark side of kinase inhibitor therapyCell Cycle2010991661166220404502
   PubMed Web of Science ®Google Scholar
• GreulichHChenTHFengWOncogenic transformation by inhibitor-sensitive and -resistant EGFR mutantsPLoS Med2005211e31316187797
   PubMed Web of Science ®Google Scholar
• BoeckxCWeynCVanden BemptIMutation analysis of genes in the EGFR pathway in head and neck cancer patients: implications for anti-EGFR treatment responseBMC Res Notes2014733724899223
   PubMedGoogle Scholar
• Al-AmriAMVatteCCyrusCNovel mutations of PIK3CA gene in head and neck squamous cell carcinomaCancer Biomark201616337738326889984
   PubMedGoogle Scholar
• MellonKWrightCKellyPHorneCHNealDELong-term outcome related to epidermal growth factor receptor status in bladder cancerJ Urol19951533 Pt 29199257853575
   PubMed Web of Science ®Google Scholar
• TannerMHollménMJunttilaTTAmplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumabAnn Oncol200516227327815668283
   PubMed Web of Science ®Google Scholar
• LoHWHsuSCHungMCEGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalizationBreast Cancer Res Treat200695321121816261406
   PubMed Web of Science ®Google Scholar
• AraújoARibeiroRAzevedoIGenetic polymorphisms of the epidermal growth factor and related receptor in non-small cell lung cancer – a review of the literatureOncologist200712220121017296816
   PubMed Web of Science ®Google Scholar
• FarneboLJedlinskiAAnsellAProteins and single nucleotide polymorphisms involved in apoptosis, growth control, and DNA repair predict cisplatin sensitivity in head and neck cancer cell linesInt J Mol Med200924454955619724896
   PubMedGoogle Scholar
• HsiehYYTzengCHChenMHChenPMWangWSEpidermal growth factor receptor R521K polymorphism shows favorable outcomes in KRAS wild-type colorectal cancer patients treated with cetuximab-based chemotherapyCancer Sci2012103479179622321154
   PubMed Web of Science ®Google Scholar
• GarrettTPMcKernNMLouMCrystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alphaCell2002110676377312297049
   PubMed Web of Science ®Google Scholar
• OgisoHIshitaniRNurekiOCrystal structure of the complex of human epidermal growth factor and receptor extracellular domainsCell2002110677578712297050
   PubMed Web of Science ®Google Scholar
• AzemarMSchmidtMArltFRecombinant antibody toxins specific for ErbB2 and EGF receptor inhibit the in vitro growth of human head and neck cancer cells and cause rapid tumor regression in vivoInt J Cancer200086226927510738256
   PubMedGoogle Scholar
• FukuokaMYanoSGiacconeGMulti-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (the IDEAL 1 trial)J Clin Oncol200321122237224612748244
   PubMed Web of Science ®Google Scholar
• LynchTJBellDWSordellaRActivating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinibN Engl J Med2004350212129213915118073
   PubMed Web of Science ®Google Scholar
• PaoWMillerVAPolitiKAAcquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domainPLoS Med200523e7315737014
   PubMed Web of Science ®Google Scholar
• HamaTYuzaYSaitoYPrognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinomaOncologist200914990090819726454
   PubMed Web of Science ®Google Scholar
• LeeJWSoungYHKimSYSomatic mutations of EGFR gene in squamous cell carcinoma of the head and neckClin Cancer Res20051182879288215837736
   PubMed Web of Science ®Google Scholar
• NaIIKangHJChoSYEGFR mutations and human papilloma-virus in squamous cell carcinoma of tongue and tonsilEur J Cancer200743352052617224267
   PubMedGoogle Scholar
• MurraySBobosMAngouridakisNScreening for EGFR mutations in patients with head and neck cancer treated with gefitinib on a compassionate-use program: A Hellenic Cooperative Oncology Group StudyJ Oncol2010201070967821274259
   PubMedGoogle Scholar
• NagalakshmiKJamilKPingaliUReddyMVAttiliSEpidermal growth factor receptor (EGFR) mutations as biomarker for head and neck squamous cell carcinomas (HNSCC)Biomarkers201419319820624712396
   PubMed Web of Science ®Google Scholar
• Lemos-GonzálezYPáez de la CadenaMRodríguez-BerrocalFJRodríguez-PiñeiroAMPallasEValverdeDAbsence of activating mutations in the EGFR kinase domain in Spanish head and neck cancer patientsTumour Biol200728527327917962724
   PubMedGoogle Scholar
• Loeffler-RaggJWitsch-BaumgartnerMTzankovALow incidence of mutations in EGFR kinase domain in Caucasian patients with head and neck squamous cell carcinomaEur J Cancer200642110911116324836
   PubMed Web of Science ®Google Scholar
• SmilekPNeuwirthovaJJarkovskyJEpidermal growth factor receptor (EGFR) expression and mutations in the EGFR signaling pathway in correlation with anti-EGFR therapy in head and neck squamous cell carcinomasNeoplasma201259550851522668015
   PubMedGoogle Scholar